Amylyx Pharmaceuticals - AMLX Net earnings per share for the last 12 months

Symbol and logo of brand amylyx.com (AMLX)

Military conflicts are blocking global neuromedicine research and disrupting component supply chains. The annual revenue per share of Amylyx Pharmaceuticals (AMLX) clearly illustrates these risks, with the value stalling at -1.45. Geopolitical instability is hindering therapy certification, while a cash deficit resulting from a drug recall is forcing Amylyx Pharmaceuticals to cut costs and revise its development plan for survival.

amylyx.com (AMLX) - Earnings per share for the last 12 months from 07/04/2022 to 11/15/2026

Comprehensive metric breakdowns and analytics for Amylyx (AMLX)

- current quotes and average value forecast:
General company analysis:amylyx.com (AMLX)
Mass-produced product of Amylyx Pharmaceuticals Inc

Long-term risk control requires an analysis of net income stability, adjusted for the impact of share issuance, which allows for an objective assessment of business profitability. Given that Amylyx Pharmaceuticals (AMLX) localizes its supply chains in Western countries, the TTM earnings per share reflect the actual financial efficiency of drug development, transforming total profit into a specific value per security.

Competitors of Amylyx Pharmaceuticals (AMLX)

biogen.com - Net earnings per share (EPS TTM)|Earnings per share for the trailing year NBIX (Neurocrine)|RGC: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Axsome Therapeutics Inc|ACAD (ACADIA Corp) - Net earnings per share (EPS TTM)|XENE: Earnings per share for the trailing year|Net earnings per share for the last 12 months VKTX (Viking Therapeutics, Inc.)|Net earnings per share (EPS TTM) Supernus Pharmaceuticals, Inc. (SUPN)|Catalyst Pharmaceuticals, Inc. - Net earnings per share for the last 12 months|Earnings per share for the last four quarters DNLI (Denali Therapeutics Inc)|Harmony Biosciences - Net earnings per share (EPS TTM)|Earnings per share for the trailing year BHVN (biohavenpharma.com)|Trevi Therapeutics, Inc. (TRVI) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Praxis Precision Medicines, Inc. (PRAX)|AVXL (anavex.com) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months CBLL (CeriBell Corp)|Earnings per share for the last twelve months Prothena Biosciences (PRTA)|Net earnings per share for the last four quarters Alector|Net earnings per share (EPS TTM) ANNX (annexonbio.com)|Earnings per share for the trailing year OMER|NGNE: Net earnings per share for the last 12 months|ACIU (AC Immune Corp) - Earnings per share for the last 12 months|VYGR: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Neumora Therapeutics, Inc. (NMRA)|SCLX (Scilex Holding) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months TVGN (Tevogen Bio)|Net earnings per share (EPS TTM) ACOG|CGTX - Net earnings per one share for the last twelve months|Inhibikase Pharma - Net earnings per share for the last 12 months|Net earnings per share for the last four quarters cassavasciences.com (SAVA)|Assertio Holdings - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Coya Therapeutics COYA|VTGN: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months OVID|Earnings per share for the last twelve months Acumen Pharmaceuticals|CRVO: Earnings per share for the trailing year|Net earnings per share (EPS TTM) ATHE|CLNN - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months PepGen Inc PEPG|Net earnings per share for the last four quarters jupiterneurosciences.com (JUNS)|Relmada Therapeutics, Inc. - Net earnings per share (EPS TTM)|Earnings per share for the trailing year ANVS (annovisbio.com)|Grace Tx (GRCE) - Earnings per share for the last twelve months|Firefly Neuroscience (AIFF) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Klotho Neurosciences Inc|neurosense-tx.com (NRSN) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Reviva Pharmaceuticals Holdings, Inc. (RVPH)|Net earnings per share (EPS TTM) MetaVia, Inc. (MTVA)|NeurAxis, Inc - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) Helius Medical HSDT|PASG - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Neuphoria Therapeutics, Inc.|Minerva Neurosciences Inc (NERV) - Earnings per share for the last twelve months|Athira Pharma, Inc. - Earnings per share for the trailing year|ADXN (Addex) - Net earnings per share (EPS TTM)|Alzamend Neuro, Inc. - Earnings per one share for the last 12 months|Net earnings per share (EPS TTM) CYCN|PTIX - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months pasitheaclinics.com KTTA|Earnings per share for the trailing year CRGT|Avenue Therapeutics Inc - Net earnings per share (EPS TTM)|Brainstorm Cell Therapeutics, Inc. (BCLI) - Net earnings per share for the last 12 months|CARA: Net earnings per share (EPS TTM)|Chromocell - Earnings per share for the trailing year|ELYM (Eliem Therapeutics, Inc.) - Net earnings per share (EPS TTM)|ITCI (intracellulartherapies.com) - Earnings per share for the last four quarters|Earnings per share for the last twelve months Longboard Pharma (LBPH)|Marinus - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) NKGN (nkgenbiotech.com)|NeuroBo Pharma - Earnings per share for the last twelve months|Sage Therapeutics Inc. - Net earnings per share (EPS TTM)|Earnings per share for the trailing year SNPX (Synaptogenix, Inc.)|TRVN (trevena.com) - Net earnings per share for the last 12 months|Net earnings per share for the last 12 months Vigil Neuroscience Inc.|Earnings per share for the last twelve months Anew Medical|CERE: Earnings per share for the trailing year